Get the Stockscreener App
238.94
0.51%
1.22
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cardinal Health Inc stock is traded at $238.94, with a volume of 2.04M.
It is up +0.51% in the last 24 hours and up +22.61% over the past month.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
See More
Previous Close:
$237.72
Open:
$239.79
24h Volume:
2.04M
Relative Volume:
0.96
Market Cap:
$55.96B
Revenue:
$250.74B
Net Income/Loss:
$1.55B
P/E Ratio:
36.54
EPS:
6.5398
Net Cash Flow:
$4.39B
1W Performance:
+1.78%
1M Performance:
+22.61%
6M Performance:
+16.15%
1Y Performance:
+47.51%
1-Day Range:
$237.53
$240.91
1-Week Range:
$233.00
$240.93
52-Week Range:
$137.75
$240.93
Cardinal Health Inc Stock (CAH) Company Profile
Name
Cardinal Health Inc
Sector
Industry
Phone
(614) 757-3033
Address
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
238.94 | 55.64B | 250.74B | 1.55B | 4.39B | 6.5398 |
MCK
Mckesson Corp
|
786.30 | 88.46B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
296.51 | 55.06B | 328.68B | 2.55B | 1.56B | 13.03 |
HSIC
Henry Schein Inc
|
86.43 | 9.51B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.52 | 1.28B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-05-25 | Upgrade | Jefferies | Hold → Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-06-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-13-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Upgrade | Argus | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Underweight |
| Jul-10-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-23 | Initiated | Citigroup | Neutral |
| Feb-03-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-04-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| May-26-22 | Downgrade | Barclays | Overweight → Equal Weight |
| May-18-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Apr-12-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Aug-06-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Underperform |
| May-10-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-21 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-25-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Jul-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-20-20 | Upgrade | BofA/Merrill | Underperform → Buy |
| Feb-12-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-16-19 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-27-19 | Downgrade | Argus | Buy → Hold |
| Aug-20-19 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-18-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-16-18 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Apr-02-18 | Upgrade | Argus | Hold → Buy |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Underperform |
| Jan-05-18 | Initiated | Evercore ISI | In-line |
View All
Cardinal Health Inc Stock (CAH) Latest News
Price to sales forward of Cardinal Health, Inc. – NYSE:CAH - TradingView
Why Is Cardinal Health (NYSE:CAH) A Value Stock In Focus? - Kalkine Media
Are Investors Undervaluing Cardinal Health (CAH) Right Now? - Yahoo Finance
Cardinal Health opens the week with analyst focus, shares in S&P 500 healthcare - AD HOC NEWS
The Kangaroo ePump Enteral Feeding Pump from Cardinal Health Inc.quiet bedside workhorse with pre - AD HOC NEWS
Cardinal Health, Inc.(NYSE: CAH) dropped from Russell 1000 Value-Defensive Index - marketscreener.com
Cardinal Health, Inc.(NYSE: CAH) dropped from Russell 1000 Growth-Defensive Index - marketscreener.com
Cardinal Health, Inc.(NYSE: CAH) dropped from Russell 1000 Defensive Index - marketscreener.com
Cardinal Health opens the week with earnings calendar, shares steady - AD HOC NEWS
Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and Revenue Growth Propel Healthcare Giant Forward - DirectorsTalk Interviews
Enterprise value to EBIT forward of Cardinal Health, Inc. – NYSE:CAH - TradingView
Cardinal Health: I Sold In 2024, Reviewing 2026 (Rating Downgrade) - Seeking Alpha
Cardinal Health opens the week with strong momentum, shares extend sector outperformance - AD HOC NEWS
Cardinal Health, Inc. Unsponsored Brazilian Depositary Receipt Repr 1 Sh - TradingView
Enterprise value to EBITDA forward of Cardinal Health, Inc. – NYSE:CAH - TradingView
Sureties SureStep Podiatry Instruments from Cardinal Health Inc.single-use focus in foot care - AD HOC NEWS
Cardinal Health charts a technical range, shares sit between key support and resistance - AD HOC NEWS
Cardinal Health, Inc. Actuals & Estimates (NYSE:CAH) - TradingView
Why the Market Dipped But Cardinal Health (CAH) Gained Today - Yahoo Finance
Cardinal Health Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Cardinal Health hits fresh high, shares ride strong health care momentum - AD HOC NEWS
Cardinal Health (CAH) Is Up 7.3% After EPS Beat And Neonatal Respiratory Tailwind NewsWhat's Changed - Sahm
Cardinal Health, Inc. (CAH) hits fresh high: Is there still room to run? - MSN
Cardinal Health clears a fresh record, shares extend the strong run on NYSE - Ad-hoc-news.de
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
What Cardinal Health (CAH) Guidance Raise Means For Valuation - Sahm
Cardinal Health (CAH) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health stock hits all-time high of 233.69 USD By Investing.com - Investing.com Nigeria
Elinor Riggs Joins Cardinal Health as SVP, CIO & CTO, Pharmaceutical & Specialty Solutions - hrtoday.in
Cardinal Health opens the week with a clear analyst picture, shares near recent highs - Ad-hoc-news.de
Cardinal Health, Inc. (CAH) - DirectorsTalk Interviews
Cardinal Health Inc (CAH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cardinal Health Stockweekly outlook with sector review - Ad-hoc-news.de
Cardinal Health (CAH) Stock Could Be 9.6% Undervalued Despite Rich P/E Signals - Yahoo Finance
Cardinal Health stock: Is CAH outperforming the healthcare sector? - MSN
Why Cardinal Health Monoject syringes quietly matter on busy wards - AD HOC NEWS
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026? - TradingView
Smart logistics in the hospital, Cardinal Health Pyxis™ Logistics keeps trays flowing - AD HOC NEWS
Should Cardinal Health’s (CAH) Raised 2026 EPS Guidance on Specialty Drugs Require Action From Investors? - Sahm
Cardinal Health Inc (CAH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cardinal Health (CAH) stock declines while market improves: Some information for investors - MSN
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Cardinal Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell? - TradingView
Cardinal Health is one of the S&P 500’s biggest decliners today. A guidance hike didn’t matter. - MSN
Cardinal Health Inc (CAH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cardinal Health Inc (CAH) Institutional Confidence - TradingKey
Cardinal Health Inc (CAH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cardinal Health Inc (CAH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cardinal Health (CAH) Gets a Buy from William O’Neil - The Globe and Mail
Cardinal Health Inc Stock (CAH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cardinal Health Inc Stock (CAH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Greene Michelle D. | Chief Information Officer |
Feb 27 '26 |
Sale |
228.47 |
2,746 |
627,387 |
12,230 |
2.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):